TARA PUCKETT: Open Payments
NPI 1942695929 · COLDWATER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 24 payments from 7 companies in 2025. Trend: 2023 $356 · 2024 $550 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $161 |
| Novo Nordisk Inc | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $47 |
| Electromed, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: AIRSUPRA, Kerendia, MOUNJARO, SMARTVEST, Ozempic, CAPLYTA, FARXIGA, Saxenda.
Industry payments across MS — which companies pay providers there.
